Use of Amphetamine-Type Stimulants Among Emergency Department Patients With Untreated Opioid Use Disorder
| Autor: | Michael S. Lyons, Lauren Whiteside, Patrick G. O'Connor, Patricia H. Owens, E. Jennifer Edelman, Richard E. Rothman, Gail D'Onofrio, Marek C. Chawarski, Judith I. Tsui, David A. Fiellin, Kathryn Hawk, Lynne D. Richardson, Shara Martel, Ethan Cowan, Edouard Coupet |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
Adult
Male medicine.medical_specialty medicine.medical_treatment Amphetamine-Related Disorders Urine Article Methamphetamine 03 medical and health sciences 0302 clinical medicine Internal medicine medicine Humans 030212 general & internal medicine Amphetamine Drug injection business.industry 030208 emergency & critical care medicine Opioid use disorder Hepatitis C Emergency department Middle Aged medicine.disease Opioid-Related Disorders United States Stimulant Substance Abuse Detection Case-Control Studies Emergency Medicine Central Nervous System Stimulants Female Drug Overdose business Emergency Service Hospital medicine.drug |
| Zdroj: | Ann Emerg Med |
| ISSN: | 1097-6760 |
| Popis: | STUDY OBJECTIVE: Concurrent use of amphetamine-type stimulants among individuals with opioid use disorder can exacerbate social and medical harms, including overdose risk. The study evaluated rates of amphetamine-type stimulant use among patients with untreated opioid use disorder presenting at emergency departments in Baltimore, MD; New York, NY; Cincinnati, OH; and Seattle, WA. METHODS: Emergency department (ED) patients with untreated opioid use disorder (N=396) and enrolled between February 2017 and January 2019 in a multisite hybrid type III implementation science study were evaluated for concurrent amphetamine-type stimulant use. Individuals with urine tests positive for methamphetamine, amphetamine, or both were compared with amphetamine-type stimulant–negative patients. RESULTS: Overall, 38% of patients (150/396) were amphetamine-type stimulant positive; none reported receiving prescribed amphetamine or methamphetamine medications. Amphetamine-type stimulant–positive versus –negative patients were younger: mean age was 36 years (SD 10 years) versus 40 years (SD 12 years), 69% (104/150) versus 46% (114/246) were white, 65% (98/150) versus 54% (132/246) were unemployed, 67% (101/150) versus 49 (121/246) had unstable housing, 47% (71/150) versus 25% (61/245) reported an incarceration during 1 year before study admission, 60% (77/128) versus 45% (87/195) were hepatitis C positive, 79% (118/150) versus 47% (115/245) reported drug injection during 1 month before the study admission, and 42% (62/149) versus 29% (70/244) presented to the ED for an injury. Lower proportions of amphetamine-type stimulant–positive patients had cocaine-positive urine test results (33% [50/150] versus 52% [129/246]) and reported seeking treatment for substance use problems as a reason for their ED visit (10% [14/148] versus 19% [46/246]). All comparisons were statistically significant at P |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect